These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 24383963)

  • 21. Steroids in acute exacerbations of chronic obstructive pulmonary disease: are nebulized and systemic forms comparable?
    Gunen H; Mirici A; Meral M; Akgün M
    Curr Opin Pulm Med; 2009 Mar; 15(2):133-7. PubMed ID: 19532028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subutilization of COPD guidelines in primary care: a pilot study.
    Laniado-Laborín R; Rendón A; Alcantar-Schramm JM; Cazares-Adame R; Bauerle O
    J Prim Care Community Health; 2013 Jul; 4(3):172-6. PubMed ID: 23799703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of severe acute exacerbation of asthma and chronic obstructive lung disease. An interview study].
    Phanareth K; Hansen EF; Laursen LC
    Ugeskr Laeger; 1997 Nov; 159(47):6985-91. PubMed ID: 9417704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nebulized bronchodilator formulations: unit-dose or multi-dose?
    Rau JL; Restrepo RD
    Respir Care; 2003 Oct; 48(10):926-39. PubMed ID: 14525629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aerosol therapy during mechanical ventilation: an international survey.
    Ehrmann S; Roche-Campo F; Sferrazza Papa GF; Isabey D; Brochard L; Apiou-Sbirlea G;
    Intensive Care Med; 2013 Jun; 39(6):1048-56. PubMed ID: 23525741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N.U.A.G.E.S: a survey of nebulisation practice in France with regard to ERS guidelines.
    de Monte M; Scruignec J; Dubus JC; Chaumuzeau JP; Dautzenberg B; Dessanges JF; Becquemin MH; Diot P;
    Respir Med; 2007 Dec; 101(12):2561-5. PubMed ID: 17869081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.
    Baumgartner RA; Hanania NA; Calhoun WJ; Sahn SA; Sciarappa K; Hanrahan JP
    Clin Ther; 2007 Feb; 29(2):261-78. PubMed ID: 17472819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Empowering family physicians to impart proper inhaler teaching to patients with chronic obstructive pulmonary disease and asthma.
    Leung J; Bhutani M; Leigh R; Pelletier D; Good C; Sin DD
    Can Respir J; 2015; 22(5):266-70. PubMed ID: 26436910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of inhaled bronchodilator therapy in patients hospitalized for non-life-threatening COPD exacerbations.
    Woods JA; Usery JB; Self TH; Finch CK
    South Med J; 2011 Nov; 104(11):742-5. PubMed ID: 22024782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of Heliox on the output and particle-size distribution of salbutamol using jet and vibrating mesh nebulizers.
    O'Callaghan C; White J; Jackson J; Crosby D; Dougill B; Bland H
    J Aerosol Med; 2007; 20(4):434-44. PubMed ID: 18158716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapy of asthma and COPD in Germany. Findings from a survey with office-based pneumologists].
    Beck E
    MMW Fortschr Med; 2012 Jun; 154 Suppl 2():27-32. PubMed ID: 23424752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
    Geller DE
    Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How do patients use their nebuliser in the community?
    Boyter AC; Carter R
    Respir Med; 2005 Nov; 99(11):1413-7. PubMed ID: 16210096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What is in the guidelines about the pharmacological treatment of chronic obstructive pulmonary disease?
    López-Campos JL; Calero Acuña C
    Expert Rev Respir Med; 2013 Apr; 7(2 Suppl):43-51. PubMed ID: 23551023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Asthma and COPD: guidance in the jungle of inhalative drugs].
    Hering T
    MMW Fortschr Med; 2015 May; 157(10):59, 61-2. PubMed ID: 26019099
    [No Abstract]   [Full Text] [Related]  

  • 36. Superiority of nebulized corticosteroids over dry powder inhalers in certain patients with cough variant asthma or cough-predominant asthma.
    Kamimura M; Izumi S; Hamamoto Y; Morita A; Toyota E; Kobayashi N; Kudo K
    Allergol Int; 2012 Sep; 61(3):411-7. PubMed ID: 22627846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple inhalers for obstructive airways disease: will they be useful?
    Barnes PJ
    Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649
    [No Abstract]   [Full Text] [Related]  

  • 38. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
    Brophy C; Kastelik J; Gardiner E; Greenstone M
    Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery.
    Miravitlles M; Soler-Cataluña JJ; Calle M; Molina J; Almagro P; Quintano JA; Riesco JA; Trigueros JA; Piñera P; Simón A; López-Campos JL; Soriano JB; Ancochea J;
    Arch Bronconeumol; 2012 Jul; 48(7):247-57. PubMed ID: 22561012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nebulized medication is not associated with nosocomial infections. A pilot study.
    Vinuesa D; Ramos V; Peña A; Ruiz-Ruigómez M; Badiola J; Muñoz-Medina L; Hernández-Quero J; Parra-Ruiz J
    Rev Esp Quimioter; 2015 Jun; 28(3):154-6. PubMed ID: 26033000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.